In 2050, antibiotic resistance may be a greater cause of death than cancer worldwide. One third to half of all young people in the Dutch-German border region receive an antibiotic treatment every year. Resistance is a growing and life-threatening problem.
Currently society is confronted with increasing resistance to existing antibiotics and insufficient development of new antibacterial agents. The pharmaceutical industry is less and less concerned with the development of new antibiotics, because this is not economically interesting.
Patch on the wound
Resistance to antibiotics is natural and a known fact. The increase has many causes. The development of new and especially smart antibiotics to combat resistance is a good development, but at the same time it is a 'patch on the wound'. Perhaps it is an illusion to think that we are getting antibiotics resistance out of the world. We can, however, ensure that dangerous microorganisms that are resistant to humans at the same time do not spread and that infections for patients remain manageable.
An example of a joint research initiative in the fight against antibiotic resistance is the Center for Sustainable Antimicrobials (CeSAM). CeSAM connects more than 40 internationally recognized scientists from the University of Groningen and the University Medical Center Groningen. The overarching goal of this joint research initiative is to conduct fundamental and translational research aimed at the development of new antibiotics, diagnosis methodologies and antimicrobial therapies. The emphasis is on tackling resistant bacterial strains, while also working on the prevention and spread of antimicrobial resistance.
Source: Dagblad van het Noorden.